Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Maryse Lapeyre-Mestre
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Geographic Areas
Concepts & Ideas
Chemicals & Drugs
Occupations
Objects
Activities & Behaviors
Disorders
Procedures
Living Beings
Sign-in to see full Profile
Network (preview)
91
Montastruc, Jean-Louis
26
Bagheri, Haleh
14
Damase-Michel, Christine
12
Sommet, Agnès
10
Rascol, Olivier
8
Senard, Jean-Michel
8
Desboeuf, Karine
7
Lacroix, Isabelle
6
Olivier, Pascale
6
Brefel-Courbon, Christine
5
Gony, Mireille
5
Lugardon, Stephanie
5
Pathak, Atul
4
Chastan, Evelyne
3
Durrieu, Geneviève
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Maryse Lapeyre-Mestre (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sommet Agnès; Shams Reza; Valnet-Rabier Marie-Blanche; Jean-Pastor Marie-Josèphe; Castot Anne; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
[Drugs and Heat Wave: SIRIUS, a Multicentric Case-Control Study in Patients Older than 65 Years During 2007 Summer in France.]
Thérapie 2009;64(5):295-301.
-
2009: Tavassoli Neda; Lapeyre-Mestre Maryse; Sommet Agnès; Montastruc Jean-Louis;
Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).
British journal of clinical pharmacology 2009;68(3):422-6.
-
2009: Fuzier Régis; Lapeyre-Mestre Maryse; Mertes Paul-Michel; Nicolas Jean-François; Benoit Yves; Didier Alain; Albert Natalie; Montastruc Jean-Louis;
Immediate- and delayed-type allergic reactions to amide local anesthetics: clinical features and skin testing.
Pharmacoepidemiology and drug safety 2009;18(7):595-601.
-
2009: Brefel-Courbon Christine; Grolleau Sabrina; Thalamas Claire; Bourrel Robert; Allaria-Lapierre Valérie; Loï Robert; Micallef-Roll Joelle; Lapeyre-Mestre Maryse
Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population.
Pain 2009;141(1-2):14-8.
-
2009: Orriols Ludivine; Gaillard Julia; Lapeyre-Mestre Maryse; Roussin Anne
Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(10):859-73.
-
2009: Olivier Pascale; Bertrand Lionel; Tubery Marie; Lauque Dominique; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey.
Drugs & aging 2009;26(6):475-82.
-
2009: Do Catherine; Huyghe Eric; Lapeyre-Mestre Maryse; Montastruc Jean Louis; Bagheri Haleh
Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(7):591-7.
-
2009: Fuzier Régis; Lapeyre-Mestre Maryse; Samii Kamran; Montastruc Jean-Louis;
Adverse drug reactions to local anaesthetics: a review of the French pharmacovigilance database.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(4):345-56.
-
2008: Molokhia Mariam; Pathak Atul; Lapeyre-Mestre Maryse; Caturla Laetitia; Montastruc Jean Louis; McKeigue Paul
Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.
British journal of clinical pharmacology 2008;66(3):386-95.
-
2008: Sommet A; Grolleau S; Bagheri H; Lapeyre-Mestre M; Montastruc J L;
Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?
European journal of clinical pharmacology 2008;64(8):829-34.
-
2008: Sailler Laurent; Attane Camille; Michenot Fleur; Canonge Jean-Marie; Rostaing Lionel; Arlet-Suau Elizabeth; Arlet Philippe; Launay François; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey.
British journal of clinical pharmacology 2008;66(2):320-2.
-
2008: Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc J L;
Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
Annals of the rheumatic diseases 2008;67(5):614-9.
-
2008: Sommet Agnès; Bagheri Haleh; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave?
Pharmacoepidemiology and drug safety 2008;17(3):312-3.
-
2008: Montastruc Jean-Louis; Lugardon Stéphanie; Desboeuf Karine; Fernet Pierre; Lapeyre-Mestre Maryse
[Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital]
Bulletin de l'Académie nationale de médecine 2008;192(2):421-30; discussion 430-1.
-
2008: Micaleff Joëlle; Jolliet Pascale; Victorri-Vigneau Caroline; Mallaret Michel; Richard Nathalie; Haramburu Françoise; Lapeyre-Mestre Maryse
[First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development]
Thérapie 2008;63(1):55-65.
-
2007: Berthet Stéphanie; Grolleau Sabrina; Brefel-Courbon Christine; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
[Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database]
Thérapie 2007;62(6):483-8.
-
2007: Roussin Anne; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature.
Fundamental & clinical pharmacology 2007;21(5):459-66.
-
2007: Lugardon S; Roussel H; Sciortino V; Montastruc J L; Lapeyre-Mestre M
Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.
European journal of clinical pharmacology 2007;63(8):801-7.
-
2007: Sailler Laurent; Puissant Bénédicte; Méliani Pascal; Castex Jean Olivier; Saivin Sylvie; Adoue D; Fournie B; Arlet Philippe; Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Pourrat Jacques; Blancher Antoine
Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.
Annals of the New York Academy of Sciences 2007;1108():41-50.
-
2007: Biga Julie; Gony Mireille; Bourrel Robert; Souche Arnaud; Sommet Agnès; Pathak Atul; Sciortino Vincent; Taboulet Florence; Grand Alain; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
Coxibs: evolution of prescription's behaviour in France.
Fundamental & clinical pharmacology 2007;21(3):317-25.
-
2007: Tavassoli N; Duchayne E; Sadaba B; Desboeuf K; Sommet A; Lapeyre-Mestre M; Muoz M J; Sie P; Honorato J; Montastruc J L; Bagheri H
Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.
European journal of clinical pharmacology 2007;63(3):221-8.
-
2007: Tavassoli Neda; Sommet Agnes; Lapeyre-Mestre Maryse; Bagheri Haleh; Montrastruc Jean-Louis
Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
Drug safety : an international journal of medical toxicology and drug experience 2007;30(11):1063-71.
-
2007: Leclerc-Foucras Sophie; Bagheri Haleh; Samii Kamran; Montastruc Jean-Louis; Lapeyre-Mestre Maryse;
Modifications of low-molecular weight heparin use in a French university hospital after implementation of new guidelines.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(5):409-17.
-
2007: Sommet Agnès; Desplas Maryline; Lapeyre-Mestre Maryse; Montastruc Jean-Louis;
Drug-induced yawning: a review of the French pharmacovigilance database.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(4):327-31.
-
2007: Boeuf Olivia; Lapeyre-Mestre Maryse;
Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(3):265-76.
-
2006: Montastruc Jean-Louis; Sommet Agnès; Lacroix Isabelle; Olivier Pascale; Durrieu Geneviève; Damase-Michel Christine; Lapeyre-Mestre Maryse; Bagheri Haleh
Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.
Joint, bone, spine : revue du rhumatisme 2006;73(6):629-32.
-
2006: Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc J L;
Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Pharmacoepidemiology and drug safety 2006;15(10):735-40.
-
2006: Lapeyre-Mestre Maryse; de Castro Ana Maria Rueda; Bareille Marie-Pierre; Del Pozo Javier Garcia; Requejo Ana Alvarez; Arias Louis Martin; Montastruc Jean-Louis; Carvajal Alfonso
Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
Fundamental & clinical pharmacology 2006;20(4):391-5.
-
2006: Lugardon Stephanie; Desboeuf Karine; Fernet Pierre; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
British journal of clinical pharmacology 2006;62(2):225-31.
-
2006: Lugardon Stéphanie; Roussel Henri; Bourrel Robert; Sciortino Vincent; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
[Patterns of non steroidal anti-inflammatory drug use in ambulatory care]
Thérapie 2006;61(2):109-14.
-
2006: Guitton Emmanuelle; Montastruc Jean-Louis; Lapeyre-Mestre Maryse;
Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.
European journal of clinical pharmacology 2006;62(3):243-9.
-
2006: Montastruc Jean-Louis; Sommet Agnès; Olivier Pascale; Bagheri Haleh; Gony Mireille; Lapeyre-Mestre Maryse; Brefel-Courbon Christine; Ferreira Joachim; Schmitt Laurent; Senard Jean-Michel; Rascol Olivier
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
Thérapie 2006;61(1):29-38.
-
2006: Carvajal Alfonso; Macias Diego; Sáinz María; Ortega Sara; Martín Arias Luis H; Velasco Alfonso; Bagheri Haleh; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
HMG CoA reductase inhibitors and impotence: two case series from the Spanish and French drug monitoring systems.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(2):143-9.
-
2005: Sommet Agnès; Juillard-Condat Blandine; Cestac Philippe; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
[Methods for the measurement of drug consumption: application to antibiotics]
Thérapie 2005;60(6):553-9.
-
2005: Tournamille Jean-François; Rigal-Huguet Françoise; Pathak Atul; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
[Cardiac effects of cytokines produced after rituximab infusion]
Bulletin du cancer 2005;92(9):769-71.
-
2005: Pathak Atul; Lapeyre-Mestre Maryse; Montastruc Jean-Louis; Senard Jean-Michel
Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1213-9.
-
2005: Biga Julie; Taboulet Florence; Lapeyre-Mestre Maryse; Duguet Anne-Marie; Vincent Sciortino; Montastruc Jean-Louis
[Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals]
Thérapie 2005;60(4):401-7.
-
2005: Biga Julie; Vigreux Philippe; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
[Muscular pain and hypolipidaemic drugs: a cross-sectional study in cardiological outpatient practice]
Thérapie 2005;60(3):295-7.
-
2005: Montastruc Jean-Louis; Bagheri Haleh; Lacroix Isabelle; Olivier Pascale; Durrieu Genevieve; Damase-Michel Christine; Lapeyre-Mestre Maryse
[New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]
Bulletin de l'Académie nationale de médecine 2005;189(3):493-502; discussion 502-5.
-
2005: Ngoundo-Mbongue T B; Niezborala M; Sulem P; Briant-Vincens D; Bancarel Y; Jansou P; Chastan E; Montastruc J L; Lapeyre-Mestre M
Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers.
Pharmacoepidemiology and drug safety 2005;14(2):81-9.
-
2005: Souchet Emmanuelle; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
Drug related falls: a study in the French Pharmacovigilance database.
Pharmacoepidemiology and drug safety 2005;14(1):11-6.
-
2004: Lapeyre-Mestre Maryse; Sulem Patrick; Niezborala Michel; Ngoundo-Mbongue Théodore Bienvenu; Briand-Vincens Dominique; Jansou Pierre; Bancarel Yannick; Chastan Evelyne; Montastruc Jean-Louis
[Taking drugs in the working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area]
Thérapie 2004;59(6):615-23.
-
2004: Micallef Joëlle; Pradel Vincent; Thirion Xavier; Jolliet Pascale; Lapeyre-Mestre Maryse
[Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects]
Thérapie 2004;59(6):581-8.
-
2004: Bagheri Haleh; Fouladi Atoussa; Barange Karl; Lapeyre-Mestre Maryse; Payen Jean-Louis; Montastruc Jean Louis; Vinel Jean-Pierre
Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.
Pharmacotherapy 2004;24(11):1546-53.
-
2004: Lugardon S; Lapeyre-Mestre M; Montastruc J L
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
European journal of clinical pharmacology 2004;60(9):673-7.
-
2004: Durrieu G; Rigal M; Bugat R; Lapeyre-Mestre M
Fertility and outcomes of pregnancy after chemotherapy in a sample of childbearing aged women.
Fundamental & clinical pharmacology 2004;18(5):573-9.
-
2004: Damase-Michel Christine; Vié Céline; Lacroix Isabelle; Lapeyre-Mestre Maryse; Montastruc J L
Drug counselling in pregnancy: an opinion survey of French community pharmacists.
Pharmacoepidemiology and drug safety 2004;13(10):711-5.
-
2004: Armand Catherine; Thirion Xavier; Saillard Carine; Lapeyre-Mestre Maryse; Lambert Henri
[Neocodion misuse: evolution between 1992 and 2002]
Thérapie 2004;59(5):547-53.
-
2004: Pathak A; Senard J M; Bujaud T; Bagheri H; Lapeyre-Mestre M; Tressieres M C; Montastruc J L
Medication error caused by confusing drug blisters.
Lancet 2004;363(9427):2142.
-
2004: Dugué A; Bagheri H; Lapeyre-Mestre M; Tournamille J F; Sailler L; Dedieu G; Salvayre R; Thouvenot J P; Massip P; Montastruc J L
Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
European journal of clinical pharmacology 2004;60(4):285-92.
-
2004: Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc J L;
Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Fundamental & clinical pharmacology 2004;18(2):201-6.
-
2004: Sanz E; Hernández M A; Ratchina S; Stratchounsky L; Peiré M A; Lapeyre-Mestre M; Horen B; Kriska M; Krajnakova H; Momcheva H; Encheva D; Martínez-Mir I; Palop V
Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia).
European journal of clinical pharmacology 2004;60(2):127-34.
-
2004: Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Gony Mireille; Lugardon Stephanie; Bagheri Haleh
[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data]
Thérapie 2004;59(2):201-5.
-
2004: Sanz E; Hernández M A; Kumari M; Ratchina S; Stratchounsky L; Peiré M A; Lapeyre-Mestre M; Horen B; Kriska M; Krajnakova H; Momcheva H; Encheva D; Martínez-Mir I; Palop V
Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria).
European journal of clinical pharmacology 2004;60(1):37-43.
-
2004: Lacroix I; Berrebi A; Chaumerliac C; Lapeyre-Mestre M; Montastruc J L; Damase-Michel C
Buprenorphine in pregnant opioid-dependent women: first results of a prospective study.
Addiction (Abingdon, England) 2004;99(2):209-14.
-
2004: Lapeyre-Mestre Maryse; Gregoire Nicolas; Bugat Roland; Montastruc Jean-Louis
Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.
Fundamental & clinical pharmacology 2004;18(1):97-105.
-
2003: Lapeyre-Mestre M; Llau M-E; Gony M; Navel A-M; Bez J; Grau M; Montastruc J-L
Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users.
Drug and alcohol dependence 2003;72(3):297-303.
-
2003: Montastuc J L; Bongard V; Lapeyre-Mestre M
Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists.
European journal of clinical pharmacology 2003;59(8-9):685-8.
-
2003: Gony Mireille; Lapeyre-Mestre Maryse; Montastruc Jean-Louis;
Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs.
Clinical neuropharmacology 2003;26(3):142-5.
-
2003: Roussel-Navarro Véronique; Bagheri Halah; Montastruc Jean-Louis; Taillefer Gilbert; Bez Jacques; Lapeyre-Mestre Maryse
[Economic impact of generic substitution in the southwest of France: study of prescription and delivery of generic drugs based on Caisse Primaire d'Assurance Maladie de la Haute-Garonne data ]
Thérapie 2003;58(2):175-7.
-
2003: Montastruc Jean-Louis; Arnaud Philippe; Barbier Catherine; Berlin Ivan; Gatignol Chantal; Haramburu Françoise; Lagier Georges; Lapeyre-Mestre Maryse; Mallaret Michel; Micaleff Joëlle
[Pharmacologic criteria for medical substitution in opiate dependence]
Thérapie 2003;58(2):123-5.
-
2003: Shin Young Je; Lapeyre-Mestre Maryse; Gafsi Inthidar; Cognard Christophe; Deguine Olivier; Tremoulet Michel; Fraysse Bernard
Neurotological complications after radiosurgery versus conservative management in acoustic neuromas: a systematic review-based study.
Acta oto-laryngologica 2003;123(1):59-64.
-
2003: Cestac Philippe; Bagheri Haleh; Lapeyre-Mestre Maryse; Sié Pierre; Fouladi Atoussa; Maupas Eric; Léger Philippe; Fontan Bernard; Massip Patrice; Montastruc Jean-Louis
Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(3):197-207.
-
2002: Horen Benjamin; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Adverse drug reactions and off-label drug use in paediatric outpatients.
British journal of clinical pharmacology 2002;54(6):665-70.
-
2002: Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Bagheri Haleh; Fooladi Atoussa
Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France.
Fundamental & clinical pharmacology 2002;16(5):343-6.
-
2002: Bongard V; Ménard-Taché S; Bagheri H; Kabiri K; Lapeyre-Mestre M; Montastruc J L
Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.
British journal of clinical pharmacology 2002;54(4):433-6.
-
2002: Oscar M A; Lapeyre-Mestre M
[Assessment of drug-related risk using expected/observed methods (standardized rate method): definition and application to pharmacovigilance]
Thérapie 2002;57(4):402-6.
-
2002: Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Bagheri Haleh; Damase-Michel Christine
[Pharmacoepidemiology in clinical practice]
La Revue du praticien 2002;52(7):701-3.
-
2002: Llau M E; Lapeyre-Mestre M; Plas L; Damase-Michel C; Montastruc J L
Forged medical prescriptions in a community pharmacy network in Midi-Pyrénées area: assessment of a falsification ratio.
European journal of clinical pharmacology 2002;57(12):911-2.
-
2002: Olivier Pascale; Boulbés Olivier; Tubery Marie; Lauque Dominique; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(14):1035-44.
-
2001: Jean R; Ducasse J L; Montastruc J L; Lapeyre-Mestre M
Treatment of acute renal colic in a French emergency department: a comparison of simulated cases and real cases in acute pain assessment and management.
European journal of clinical pharmacology 2001;57(9):685-9.
-
2001: Olivier P; Boulbès O; Tubery M; Carles P; Montastruc J L; Lapeyre-Mestre M
[Preventability of adverse effects in a medical emergency service]
Thérapie 2001;56(3):275-8.
-
2001: Bagheri H; Lapeyre-Mestre M; Levy C; Haramburu F; Hillaire-Buys D; Blayac J P; Montastruc J L
[Inter-regional differences in dysthyroidism due to amiodarone: comparison of spontaneous notifications in Aquitaine, Midi-Pyrenees and Languedoc-Roussillon]
Thérapie 2001;56(3):301-6.
-
2001: Lemoine T; Lacroix I; Lapeyre-Mestre M; Montastruc J L; Damase-Michel C
[Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center']
Thérapie 2001;56(3):287-93.
-
2001: Montastruc J L; Desboeuf K; Lapeyre-Mestre M; Senard J M; Rascol O; Brefel-Courbon C
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):511-4.
-
2001: Montastruc J L; Brefel-Courbon C; Senard J M; Bagheri H; Ferreira J; Rascol O; Lapeyre-Mestre M
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
Clinical neuropharmacology 2001;24(3):181-3.
-
2001: Bareille M P; Montastruc J L; Lapeyre-Mestre M
[Liver damage and nonsteroidal anti-inflammatory drugs: case non-case study in the French Pharmacovigilance Database]
Thérapie 2001;56(1):51-5.
-
2000: Lacroix I; Damase-Michel C; Lapeyre-Mestre M; Montastruc J L
Prescription of drugs during pregnancy in France.
Lancet 2000;356(9243):1735-6.
-
2000: Bagheri H; Michel F; Lapeyre-Mestre M; Lagier E; Cambus J P; Valdiguié P; Montastruc J L
Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.
British journal of clinical pharmacology 2000;50(5):479-84.
-
2000: Couffignal A L; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc J L
[Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution]
Thérapie 2000;55(5):635-41.
-
2000: Montastruc J L; Chaumerliac C; Desboeuf K; Manika M; Bagheri H; Rascol O; Lapeyre-Mestre M
Adverse drug reactions to selegiline: a review of the French pharmacovigilance database.
Clinical neuropharmacology 2000;23(5):271-5.
-
2000: Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc J L
[Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region]
Archives des maladies du coeur et des vaisseaux 2000;93(8):925-9.
-
2000: Brefel-Courbon C; Simonetta-Moreau M; Moré C; Rascol O; Clanet M; Montastruc J L; Lapeyre-Mestre M
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.
Clinical neuropharmacology 2000;23(4):203-7.
-
2000: Rémy N; Lapeyre-Mestre M; Bareille M P; Bagheri H; Montastruc J L
[Drug interactions: a prospective pilot study in primary health care]
Thérapie 2000;55(3):395-8.
-
2000: Damase-Michel C; Lapeyre-Mestre M; Moly C; Fournié A; Montastruc J L
[Drug use during pregnancy: survey in 250 women consulting at a university hospital center]
Journal de gynécologie, obstétrique et biologie de la reproduction 2000;29(1):77-85.
-
1999: Desboeuf K; Lapeyre-Mestre M; Montastruc J L
[Calcium inhibiting drugs and the risk of gastrointestinal hemorrhage. A pharmaco-epidemiologic case-non-case study]
Archives des maladies du coeur et des vaisseaux 1999;92(8):1095-9.
-
1999: Bagheri H; Damase-Michel C; Lapeyre-Mestre M; Cismondo S; O'Connell D; Senard J M; Rascol O; Montastruc J L
A study of salivary secretion in Parkinson's disease.
Clinical neuropharmacology 1999;22(4):213-5.
-
1999: Lapeyre-Mestre M; Chastan E; Louis A; Montastruc J L
Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986).
Journal of clinical epidemiology 1999;52(5):471-8.
-
1999: Montastruc J L; Bagheri H; Lapeyre-Mestre M; Senard J M
[Pharmacological vigilance and pharmacological epidemiology: principles, definition, methods and current trends in neurology]
Revue neurologique 1999;155(4):312-24.
-
1998: Desboeuf K; Lapeyre-Mestre M; Montastruc J L
Risk of gastrointestinal haemorrhage with calcium antagonists.
British journal of clinical pharmacology 1998;46(1):88-9.
-
1998: Lapeyre-Mestre M; Desboeuf K; Aptel I; Chale J J; Montastruc J L
A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.
Clinical drug investigation 1998;16(1):53-61.
-
1997: Senard J M; Raï S; Lapeyre-Mestre M; Brefel C; Rascol O; Rascol A; Montastruc J L
Prevalence of orthostatic hypotension in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;63(5):584-9.
-
1997: Montastruc J L; Sénard J M; Lapeyre-Mestre M
[Apropos of recent antidepressant drugs: some pharmacological comments]
Thérapie 1997;52(2):143-9.
-
1997: Montastruc J L; Bagheri H; Geraud T; Lapeyre-Mestre M
[Pharmacovigilance of self-medication]
Thérapie 1997;52(2):105-10.
-
1997: Lapeyre-Mestre M; Damase-Michel C; Adams P; Michaud P; Montastruc J L
Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Community pharmacists of the Midi-Pyrénées.
European journal of clinical pharmacology 1997;52(1):37-9.
-
1996: Riotte C; Duchesne P; Lapeyre-Mestre M; Pezous A M; Bagheri H; Damase-Michel C; Schmitt L; Montastruc J L
[Pharmacoepidemiological study of methadone in a center of addiction management: adverse effects and combined drug consumption]
Thérapie 1996;51(5):557-9.
-
1996: Lemozit J P; De La Rhodiere G P; Lapeyre-Mestre M; Bagheri H; Montastruc J L
A comparative study of adverse drug reactions reported through hospital and private medicine.
British journal of clinical pharmacology 1996;41(2):166-8.
-
1995: Lemozit J P; Vabre F; Lapeyre-Mestre M; Damase-Michel C; Montastruc J L
[Could you give me this drug without prescription?]
Thérapie 1995;50(5):464-6.
-
1995: Pouget-Zago P; Lapeyre-Mestre M; Bagheri H; Montastruc J L
[Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region]
Thérapie 1995;50(5):459-62.
-
1995: Sacilotto K; Bagheri H; Lapeyre-Mestre M; Montastruc J L; Montastruc P
[Adverse drug effect notifications by nurses and comparison with cases reported by physicians]
Thérapie 1995;50(5):455-8.
-
1994: Montastruc J L; Lapeyre-Mestre M; Llau M E; Senard J M; Rascol O; Montastruc P
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1994;4(6):303-5.
-
1994: Llau M E; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
[Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992]
Thérapie 1994;49(2):123-7.
-
1992: Lapeyre-Mestre M; Chave B; Rascol O; Senard J M; Lafont J; Montastruc J L
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]
Thérapie 1992;47(5):444-5.
-
1992: Lapeyre-Mestre M; Chave B; Montastruc J L
[Development of antibiotic consumption at the Regional University Hospital Center of Toulouse from 1980 to 1989]
Thérapie 1992;47(1):57-61.
-
1991: Lapeyre-Mestre M; Lebret-Bories E; Charlet J P; Montastruc J L; Montastruc P
[Consumption of drugs in a population of school age subjects]
Thérapie 1991;46(1):49-53.
Sign-in to see more
